Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Implants & Prosthetics

Enovis EMPOWR 3D Knee Tibial Inserts Recalled for Incorrect Labeling

Agency Publication Date: August 8, 2025
Share:
Sign in to monitor this recall

Summary

Encore Medical, LP (Enovis) is recalling 58 EMPOWR 3D Knee Tibial Insert - E-PLUS implants because they were shipped with incorrect labeling. The labels may list the wrong size or side (left versus right), which could lead to the wrong component being selected for a patient's total knee replacement surgery. These implants are used in surgeries to restore mobility and reduce pain in patients who are candidates for knee arthroplasty.

Risk

If an incorrectly labeled implant is used during surgery, a patient could receive a component that does not fit correctly or is for the wrong side of the body. This could result in surgical delays, poor joint function, or the need for a follow-up revision surgery.

What You Should Do

  1. The recalled products are Enovis EMPOWR 3D Knee Tibial Insert - E-PLUS implants with model numbers 341-16-704 or 342-16-707. Affected lot numbers include 148T1057, 161T1053, and 161T1054.
  2. Stop using the recalled knee implants immediately and quarantine any remaining stock at your facility.
  3. Contact Encore Medical, LP (Enovis) or your authorized distributor to arrange for the return, replacement, or correction of the affected devices.
  4. Call the FDA: 1-888-463-6332 (1-888-INFO-FDA) if you have further questions regarding this recall.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS (4L 16MM)
Variants: 4L, 16MM
Model / REF:
341-16-704
Lot Numbers:
148T1057
GTIN:
00888912167116

Quantity: 18 implants

Product: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS (7R 16MM)
Variants: 7R, 16MM
Model / REF:
342-16-707
Lot Numbers:
161T1053
161T1054
GTIN:
00888912167642

Quantity: 40 implants

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97188
Status: Active
Manufacturer: Encore Medical, LP
Sold By: Hospitals; Surgical Centers; Authorized Medical Device Distributors
Manufactured In: United States
Units Affected: 2 products (18 implants; 40 implants)
Distributed To: Alabama, Arizona, California, Colorado, Florida, Iowa, Illinois, Indiana, Kansas, Louisiana, New York, Tennessee, Texas
Agency Last Updated: February 23, 2026

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.